Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Curtiss

Showing results (91-100 of 351) with videos related to

Pageof 36
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Real-world research in diabetes care and protocols for patient privacyFrederic R Curtiss
American Journal of Hospital Pharmacy|January 1, 1986
Recent developments in federal reimbursement for home health careF R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Disease management of ADHD and measures of complianceFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Reducing the risk of fractures--the options narrow for cost-effective therapeutic alternativesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Which triptan?--Opportunity for same or better outcomes at lower costFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Does member cost sharing pose a threat to desirable patient outcomes?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|August 10, 2004
Clinical pharmacist intervention in a primary care medical group reduces financial lossesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|August 10, 2004
Step-therapy edits for PPIs and COX-2 drugs. What we do and do not knowFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 26, 2005
P&T committees--black boxes versus AMCP format, and what is the true cost and value of pimecrolimusFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 3, 2005
COX-2 inhibitors: little or no GI protection, increased risk of cardiovascular events, high cost, and other class-less effectsFrederic R Curtiss
Pageof 36

Showing results (91-100 of 351) with videos related to

Sort By:
Pageof 36
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Real-world research in diabetes care and protocols for patient privacyFrederic R Curtiss
American Journal of Hospital Pharmacy|January 1, 1986
Recent developments in federal reimbursement for home health careF R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Disease management of ADHD and measures of complianceFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|March 23, 2004
Reducing the risk of fractures--the options narrow for cost-effective therapeutic alternativesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Which triptan?--Opportunity for same or better outcomes at lower costFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|July 2, 2004
Does member cost sharing pose a threat to desirable patient outcomes?Frederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|August 10, 2004
Clinical pharmacist intervention in a primary care medical group reduces financial lossesFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|August 10, 2004
Step-therapy edits for PPIs and COX-2 drugs. What we do and do not knowFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|January 26, 2005
P&T committees--black boxes versus AMCP format, and what is the true cost and value of pimecrolimusFrederic R Curtiss
Journal of Managed Care Pharmacy : JMCP|September 3, 2005
COX-2 inhibitors: little or no GI protection, increased risk of cardiovascular events, high cost, and other class-less effectsFrederic R Curtiss
Pageof 36